RxDoctor Payments Data

Rebecca Smith, NP

Nurse Practitioner · Indianapolis, INNPI 1417249988

Payments from drug & device makers

$969in general payments, 2019–2025

Across 47 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$203
  • Medtronic$178
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$98
  • Abbott$91
  • Boston Scientific$82
  • Collegium Pharmaceutical, Inc.$63
  • plus $253 from 11 others

What the payments were for

  • Food & beverage$969100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$969 in reported general payments places this provider in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$29,386
Medicare patients
62
Services billed
278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl30$23,653
Buprenorphine37$10,976
Xtampza ErOxycodone Myristate15$8,638
NucyntaTapentadol Hcl19$7,621
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen146$4,420
Celecoxib33$4,213
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen54$1,627
Oxycodone Hcl91$1,355
Gabapentin85$1,239
Pregabalin63$1,211
Morphine Sulfate ErMorphine Sulfate42$781
Naloxone Hcl11$719
Tramadol Hcl90$575
Baclofen21$494
Duloxetine Hcl24$466

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta$63$39,91264 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →